Eli Lilly and Co (BSP:LILY34)
R$ 130.52 -2.2 (-1.66%) Market Cap: 3.72 Til Enterprise Value: 3.84 Til PE Ratio: 113.84 PB Ratio: 56.38 GF Score: 73/100

Eli Lilly and Co Investment Community Meeting Transcript

Dec 15, 2021 / 02:00PM GMT
Release Date Price: R$52.12 (+10.25%)
Kevin Hern
Eli Lilly and Company - VP of IR

Good morning, everyone. Thanks for joining us at Eli Lilly and Company's 2021 Investment Community Meeting. I'm Kevin Hern, the Vice President of Investor Relations. I'd like to welcome individuals from the sell-side firms, institutional investors, rating agencies and media who are in the audience today here at the New York Stock Exchange. We're delighted you joined us, and we're excited to be here with you today. I'd like to also welcome those of you who are joining us by watching this event through the videocast on our website.

Lilly's purpose is to create new medicines that make life better for millions of people around the world. Today, we'll be highlighting the exciting opportunity we have to continue to fulfill that purpose for more patients as our newer medicines and potential upcoming launches drive further growth through the decade as well as showcase the next generation of assets across our 4 therapeutic areas that we believe will enable us to sustain the flow of innovation to patients and augment our future growth prospects.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot